PRDX5 and endometrial cancer: Moreover, Han et al. [12] demonstrated that the level of PRDX5 was elevated and PRDX5 expression in endometrial cancer was significantly associated with a poorer survival rate, suggesting that PRDX5 may be a clinically prognostic biomarker for the development of endometrial cancer.